Sildenafil Citrate

Sildenafil Citrate API (CAS No: 171599-83-0) is a widely recognized pharmaceutical compound used in the development of specialized therapeutic formulations. As a selective phosphodiesterase type 5 (PDE5) inhibitor, it is extensively incorporated in formulations requiring targeted vasodilatory action and controlled pharmacological performance.

This material is primarily utilized in the production of oral solid dosage forms, including tablets and capsules, designed for regulated and semi-regulated markets. Its well-established profile, formulation compatibility, and consistent performance make it a preferred choice for pharmaceutical manufacturers engaged in high-demand therapeutic segments.

The product is supplied in accordance with internationally accepted pharmacopeial standards, including USP, BP, and EP (as applicable). It is handled under controlled conditions to ensure high purity, batch-to-batch consistency, and compliance with global quality expectations. Each supply is supported with standard documentation aligned with international regulatory requirements.

Kelar Pharmachem India operates as a reliable global sourcing partner for Sildenafil Citrate API, ensuring consistent availability through validated supply networks. The product is delivered in export-compliant packaging designed to maintain stability and integrity during storage and international transit, with flexible packaging solutions available based on client specifications.

The company supports pharmaceutical manufacturers across key global markets, including Asia, Africa, the Middle East, and Latin America. With a focus on long-term collaboration, Kelar Pharmachem India offers dependable supply, competitive positioning, and professional export support tailored to international business needs.